Introduction
The v-jun oncogene is the transforming determinant of avian sarcoma virus 17 (ASV17), a retrovirus isolated from a chicken ®brosarcoma (Maki et al., 1987) . Expression of v-jun induces neoplastic transformation of avian ®broblasts and ®brosarcomas in chicken Wong et al., 1992; Jurdic et al., 1995) . The v-Jun oncoprotein represents a mutated version of its cellular counterpart c-Jun (Nishimura and Vogt, 1988) and operates as a constitutive active component of the transcription factor complex AP-1 (activating protein 1) (Vogt, 2001) . AP-1 represents a collection of sequence-speci®c DNA binding dimers consisting of Jun, Fos or ATF protein family members (Curran and Vogt, 1991; Karin et al., 1997; Wisdom, 1999; Van Dam and Castellazzi, 2001) . Gene regulation by AP-1 is essential for cell proliferation and dierentiation (Shaulian and Karin, 2001; Angel et al., 2001; Jochum et al., 2001) . Constitutive activation of endogenous AP-1 is required for tumor formation in distinct avian and mammalian cell transformation systems indicating that AP-1 plays an important role in oncogenesis (Apel et al., 1992; Suzuki et al., 1994; Saez et al., 1995; Johnson et al., 1996; Mann et al., 1999; Young et al., 1999) . Due to its biochemical function as a transcriptional regulator, neoplastic cell transformation induced by vJun or by constitutive active AP-1 components presumably involves aberrant expression of speci®c genes that are normally regulated by AP-1 Vogt, 2001; Van Dam and Castellazzi, 2001) .
Approaches aimed at the identi®cation of genes speci®cally deregulated in jun-or fos-transformed primary avian ®broblasts, a cellular system in which these oncogenes autonomously induce cell transformation and tumorigenesis (Maki et al., 1987; Nishizawa et al., 1987) , have led to the identi®cation of several jun target genes. The activated genes include BKJ, encoding a hydrophobic protein structurally related to avian epidermal b-keratins Bister, 1995, 1998) , JTAP-1, encoding a cathepsin-like proteinase (Hadman et al., 1996) , glutaredoxin, encoding a redox cofactor in the biosynthesis of deoxyribonucleotides (Goller et al., 1998) , HB-EGF, encoding heparinbinding epidermal growth factor-like growth factor , RIL, encoding reversion-induced LIM protein (Fu et al., 2000) , and JAC, encoding a novel cysteine-rich protein with unknown function (Bader et al., 2000) . From these genes, BKJ, glutaredoxin, HB-EGF, and JAC represent transcriptional targets directly regulated by v-Jun as demonstrated by promoter analysis of the BKJ gene (Hartl and Bister, 1998) and by usage of conditional cell transformation systems (Kruse et al., 1997; Goller et al., 1998; Bader et al., 2000) . In addition to upregulated targets, several genes are known to be suppressed in v-jun-transformed cells (Hadman et al., 1998; Mettouchi et al., 1994; Vial and Castellazzi, 2000; Cohen et al., 2001) . Hence, due to the apparent deregulation of multiple genes, it is suggested that only the combined dierential expression of v-Jun target genes or of a subset thereof enables the conversion of a normal ®broblast into a tumor cell that displays a phenotype typical for v-jun-induced cell transformation. This hypothesis is supported by the recent identi®cation of the upregulated direct v-jun target gene HB-EGF, which displays partial transforming properties upon ectopic expression .
In this study we have identi®ed four additional jun target genes using a conditional v-jun-transformation system established recently (Bader et al., 2000) . These novel targets are characterized by their speci®city in aberrant upregulation. One of them, termed TOJ3, encodes a protein that is highly related to mammalian nucleolar proteins. TOJ3 is immediately induced after conditional jun activation and induces transformation of avian ®broblasts when expressed from a retroviral vector.
Results

Genes specifically induced upon conditional activation of v-jun
We have previously developed the conditional cell lines Q/d3 and Q/VII in which transcriptional expression of the v-jun oncogene is controlled by a Figure 1 Isolation and expression analysis of genes immediately activated upon conditional induction of v-jun. (A) Representational dierence analysis (RDA) using two mRNA populations, one isolated from Q/d3 cells cultured in the absence of doxycycline (driver) and the other from the same cell line 24 h after the addition of doxycycline (tester). Equal amounts (3 mg) of cDNA from the tester population (Tester), and from the dierence products (DP) obtained after each of three successive hybridization/ampli®cation steps was analysed by agarose(1.5% w/v) gel electrophoresis. The positions of enriched tester-speci®c cDNAs isolated from the gel (DP3) are indicated by arrows. Positions of DNA marker fragments (M) are indicated in the left margin. (B) Transcriptional activation of genes represented by the clones TOJ3, TOJ2, TOJ5, TOJ6, and of BKJ in conditionally and non conditionally transformed quail ®broblasts. Northern analysis of equal amounts (2.5 mg) of poly(A) + RNAs derived from normal quail embryo ®broblasts (QEF) (lane 1), from QEF transfected with the empty retroviral RCAS vector (lane 2), from QEF transfected with the retroviral constructs RCAS-VJ1 (lane 3) and RCAS-MC29 (lane 6) encoding v-Jun and v-Myc, respectively, from QEF transformed by the ASV17 (lane 4) or NK24 (lane 5) retroviruses carrying the v-jun or v-fos oncogenes, respectively, from the cell lines VJ (v-jun) (lane 7), Q8 (v-myc) (lane 8), R(-)3 (v-src) (lane 9), MH2A10 (v-myc/v-mil) (lane 11) which carry the oncogenes listed in parenthesis, from QT6 (lane 10), a cell line chemically transformed by methylcholanthrene, and from the cell lines Q/d3 (lanes 12, 13) or Q/tM on (lanes 14, 15) conditionally transformed by v-jun or v-myc, respectively, carrying a doxycycline-dependent reverse transactivator. Reverted Q/d3 and Q/tM on cells grown in the absence of doxycycline ( ± ) for 6 days (lanes 12, 14) were retransformed upon addition of doxycycline for 24 h (+) (lanes 13, 15). The ®lter was successively hybridized with 32 P-labeled quail cDNA probes derived from TOJ3 (2.5610 6 c.p.m./ml, 96-h exposure), TOJ2 (1.0610 6 c.p.m./ ml, 14-day exposure), TOJ5 (0.9610 6 c.p.m./ml, 27-h exposure), TOJ6 (1.0610 6 c.p.m./ml, 90-h exposure), BKJ (1.0610 6 c.p.m./ ml, 48-h exposure), and GAPDH (1.0610 6 c.p.m./ml, 21-h exposure). Autoradiography was performed using an intensifyer screen. The sizes of the mRNAs are 2.0 kb (TOJ3), 5.2 kb (TOJ2), 3.5 and 2.7 kb (TOJ5), 2.2 kb (TOJ6), 0.8 kb (BKJ), and 1.4 kb (GAPDH). The positions of residual ribosomal RNAs in the top panel are indicated in the left margin doxycycline-dependent transactivator (Bader et al., 2000) . Depletion of doxycycline from these cells leads to silencing of v-jun expression and subsequent reversion of the jun-transformed phenotype. Readdition of the drug to the reverted cells leads to rapid re-activation of v-jun mRNA and protein within 1 ± 4 h and to subsequent morphological alterations and cell transformation after 1 ± 3 days (Bader et al., 2000) . To identify genes that are immediately activated upon conditional induction of v-jun, representational dierence analysis (RDA) (Hubank and Schatz, 1994) was performed using mRNAs isolated from the conditional cell line Q/d3 grown under non-permissive and under permissive conditions as driver and tester, respectively. RNA was isolated from aliquots of reverted Q/d3 cells (driver) and from Q/d3 cells 24 h after the addition of doxycycline (tester). After three rounds of hybridization and ampli®cation, three major ethidium bromide-stained dierence products varying in their ®nal yields were detected after agarose gel electrophoresis representing highly enriched tester cDNAs ( Figure 1A ). Subcloning and DNA sequencing resulted in the identi®cation of four distinct RDA cDNA clones termed TOJ2, TOJ3, TOJ5, and TOJ6 (target of Jun). In computerized sequence homology searches, the sequences of two RDA clones showed similarities to known chicken genes: clone TOJ2 to the gene encoding the a7 subunit of nicotinic acetylcholine receptor (Schoepfer et al., 1990) and clone TOJ6 to the gene encoding myosin binding protein-H (MyBP-H) (Vaughan et al., 1993) , whereas no signi®cant similarities were found for the sequences of the TOJ3 or TOJ5 clones, possibly due to the short size of the RDA fragments (Table  1) . To investigate if elevated expression of genes represented by these clones in retransformed Q/d3 cells could re¯ect a correlation with jun-induced cell transformation, their expression was tested in a variety of transformed and non-transformed quail embryo ®broblasts (QEF). Northern analysis ( Figure  1B ) using RNAs from QEF transformed by various oncogenes (lanes 3 ± 9, 11, 13, 15) and the four RDA fragments as probes revealed speci®c expression of genes corresponding to the TOJ clones in vjun-transformed cells (lanes 3, 4, 7, 13) similar to speci®c activation of the direct AP-1 target gene BKJ (Hartl and Bister, 1998) . However, in contrast to BKJ, none of the TOJ-speci®c genes was activated in ®broblasts transformed by the v-fos oncogene (lane 5) suggesting that v-Fos/Jun dimers are not involved in the upregulation of these genes. Remarkably, all tested genes were activated within 24 h upon conditional v-jun mRNA induction (lane 13). Using the TOJ probes, no expression was detected in normal cells (lanes 1, 2) nor in cells transformed by the v-myc (lanes 6, 8), v-myc/v-mil (lane 11) or v-src (lane 9) oncogenes, nor in chemically transformed ®broblasts (lane 10) ( Figure  1B) . Furthermore, no activation of the TOJ-speci®c genes was detected in an analogous conditional cell transformation system in which addition of doxycycline leads to activation of the v-myc oncogene (Oberst et al., 1999) (lanes 14, 15) indicating that activation of these genes is speci®cally linked to the presence of the Jun oncoprotein ( Figure 1B ). TOJ2 and TOJ3-speci®c RNAs were expressed in all juntransformed cell types tested (lanes 3, 4, 7, 13), whereas TOJ5 or TOJ6-speci®c RNAs were not detectable by Northern analysis in QEF transformed by the construct RCAS-VJ1 (lane 3) or by ASV17 (lane 4), respectively ( Figure 1B) . Furthermore, the expression levels of TOJ3 or BKJ in dierent v-juntransformed cells varied although comparable amounts of v-Jun protein are expressed in these cells (data not shown). Due to its strong induction in retransformed Q/d3 cells ( Figure 1B ), the TOJ3 clone was chosen for further characterization.
Structure of the TOJ3 cDNA
Using the 175-bp RDA fragment of the TOJ3 clone as a probe, a cDNA library constructed from Q/d3 cells was screened leading to the isolation of three speci®cally hybridizing clones, TOJ3_F1, TOJ3_F3, and TOJ3_F4 with insert sizes of 1722, 1616, and 1718 bp, respectively ( Figure 2A ). The sequence of the 175-nt RDA fragment is located in the 5'-part of the assembled cDNA ( Figure 2B ) but no poly(A) tail was found in any of the clones. The 5'-prime end of the mRNA was de®ned by primer extension analysis ( Figure 2C ) and by rapid ampli®cation of cDNA ends (RACE) leading to the determination of additional 18 nucleotides upstream of clone TOJ3_F1. To de®ne the mRNA 3'-end, 3'-RACE was carried out leading to identi®cation of the polyadenylation attachment site just at the 3'-end of clone TOJ3_F4 (data not shown). The assembled full-length cDNA sequence without poly(A) tail encompasses 1772 bp ( Figure 2B ) which is in very good agreement with the size of the relevant mRNA of 2.0 kb (cf. Figure 1B) . The longest open reading frame of the cDNA encodes a 530-amino acid protein with a M r of 57 929 and an estimated isolelectric point of 10.22. 8 c.p.m./mg) as a primer in the reverse transcription reaction. The same unlabeled oligodeoxynucleotide was also applied as primer in a sequencing reaction (lanes G, A, T, C) using a 5'-truncated quail TOJ3 cDNA insert ligated into pUC19 as a template. Autoradiography of the sequencing gel using an intensifying screen was performed for 96 h. The size of the extended product is indicated in the margin
The protein product of TOJ3 is related to nucleolar proteins Sequence analysis of the TOJ3-speci®c 1772-bp cDNA and of the predicted 530 amino acid-polypeptide (cf. Figure 2 ) revealed apparent similarities to human sequences corresponding to the microspherule protein 1 (MCRS1) p78 (Bruni and Roizman, 1998) , also designated as 58-kDa microspherule protein MSP58 (Ren et al., 1998) (Table 1 ). The MCRS1 protein is located in cellular nucleoli where it interacts with the nuclear regulatory protein ICP22 from herpes simplex virus 1, and accumulates in a cell cycle-dependent manner (Bruni and Roizman, 1998) . MSP58 was identi®ed as an interaction partner of the proliferationrelated nucleolar protein p120 which reaches peak levels in early S phase of the cell cycle (Ren et al., 1998) and is expressed at high levels in a variety of human malignant tumor cells (Freeman et al., 1988) . The alignment of the 530-amino acid quail protein with the 534-amino acid human MCRS1, the 462-amino acid human MSP58, and the 462-amino acid murine MCRS1 proteins ( Figure 3 ) shows that the predicted quail protein shares a high degree of sequence identity in the carboxyl terminal 448 residues with all compared mammalian sequences. Interestingly, except of four amino terminal residues, the human MCRS1 and MSP58 proteins share identical sequences, and the murine protein designated as MCRS1 apparently represents the MSP58 orthologue ( Figure 3 ). Therefore, MSP58 presumably represents a shorter isoform of MCRS1. Although similar in size, the 84-amino acid amino terminal region of the quail protein does not share any sequence similarities with human MCRS1. Amino acid sequence motifs characteristic for nuclear proteins are present in TOJ3 and in homologous regions of the related mammalian proteins ( Figure 3 ) including a bipartite nuclear localization signal Laskey, 1991, 1998) in the amino terminal region and a forkhead associated domain (FHA) (Hofmann and Bucher, 1995; Durocher et al., 1999) located in the carboxyl terminal region. FHA domains are thought to represent nuclear signaling domains present in protein kinases and transcription factors mediating phosphorylation-dependent protein-protein interactions (Durocher et al., 1999; Wang et al., 2000) . Identi®cation of these sequence motifs in the TOJ3 protein product strongly suggests that the predicted protein is subject to posttranslational transport into the nucleus.
Kinetics of TOJ3 mRNA activation
The conditional cell line Q/VII in which transcription of the ASV17 v-jun allele is controlled by a doxycycline-dependent transactivator (Bader et al., 2000) was used to determine the kinetics of TOJ3 activation upon conditional induction of oncogenic jun. Figure 4 shows an analysis of the time course of TOJ3 activation following removal and readdition of doxycycline compared with activation of the BKJ gene which is directly activated by v-Jun at the promoter level (Hartl and Bister, 1998) . TOJ3 is expressed at low levels in Q/VII cells cultured under permissive conditions (-6d) similar to its expression level in cells non-conditionally transformed by v-jun (cf. Figure 1 ). At time point zero (6 days after removal of doxycycline), the v-jun allele was shut o completely and no mRNA levels of TOJ3 were detectable. Simultaneously, c-jun which is suppressed in v-jun-transformed cells (Bader et al., 2000) was re-expressed in the reverted cells. Following conditional v-jun induction, re-expression of both TOJ3 and BKJ mRNAs was ®rst detected only 7 h after readdition of doxycycline reaching maximum levels after 2 days. This immediate response highly suggests that TOJ3 is directly activated by v-Jun similar to BKJ. However, whereas BKJ expression Figure 3 Alignment of amino acid sequences of quail (q) TOJ3 protein and of its closest relatives, the human (h) and mouse (m) microspherule proteins MCRS1 and the human MSP58 protein (GenBank accession nos. AAG16624, NP_006328, AAH03746, and AAC52086, respectively). Amino acids are numbered in the margin and identical amino acid residues are shaded in yellow. The potential bipartite nuclear targeting sequence motif [K/R K/R (X) 10 ± 12 K/R K/R K/R] (Dingwall and Laskey, 1991) encompassing TOJ3 residues 102 ± 116 and the forkhead associated domain (FHA) (Hofmann and Bucher, 1995) encompassing TOJ3 residues 431-503 are labelled with red and blue boxes, respectively levels persisted at constantly high levels during the time course, strong TOJ3 induction was of transient nature being silenced after 2 ± 3 days to a level comparable to its expression in non-treated Q/VII cells (Figure 4) . Similar transient expression kinetics of TOJ3 was observed also in equally treated Q/d3 cells (unpublished data) .
It has been shown that expression of the MCRS1 (p78) protein is cell cycle dependent, accumulating in the very early S phase (Bruni and Roizman, 1998) . To distinguish if the strong transient activation of TOJ3 was speci®cally linked to conditional induction of the v-Jun oncoprotein or more due to a re-entry into the cell cycle of retransformed Q/VII or Q/d3 cells (Bader et al., 2000) , TOJ3 expression was tested in normal QEF which have ®rst been arrested in the G 0 phase by serum starvation and then treated with serum to reenter the cell cycle. Figure 5 shows, that growth factor stimulation of QEF leads to the typical expression Figure 5 Transcriptional activation of TOJ3 and BKJ after conditional v-jun induction but not after growth factor-induced cjun activation. Transformed Q/d3 cells containing a reverse transactivator-dependent v-jun allele and grown continuously in the presence of doxycycline were depleted of the drug. After 6 days of incubation without doxycycline, the drug was re-added to the reverted cells (time 0 in Q/d3), and cell culturing was continued for the time points indicated. Normal QEF seeded at a density of 6610 6 cells per 100-mm dish were serum-starved by subsequent cultivation ®rst in medium containing 0.5 % serum and then in medium containing 0.25% serum for each 2 days (time 0 in QEF). For serum-stimulation of immediate early genes, medium containing 15% serum was added to the quiescent QEF and RNA was extracted at the time points indicated. Equal amounts (15 mg) of total RNA from the indicated cell sources were analysed. The ®lter was successively hybridized with pro®le characteristic for immediate early genes like cjun, c-fos, or c-myc, reaching peak levels 1 h after serum addition (Lamph et al., 1988) . Despite the fact, that levels of serum-induced c-jun mRNA in QEF were comparable to those of conditionally induced v-jun mRNA in Q/d3 cells, neither TOJ3 nor BKJ were activated in serum stimulated QEF (Figure 5 ), indicating that transcriptional activation of these target genes requires the oncogenic function of Jun.
Activation of TOJ3 monitored at the protein level
To characterize the TOJ3 protein product, an immunoanity puri®ed polyclonal antibody preparation (a-TOJ3) was generated directed against the nonconserved amino terminus (cf. Figure 3) of the predicted quail TOJ3 protein. The antibodies were ®rst used to detect in vitro transcribed and translated TOJ3 using the coding sequence of the TOJ3 cDNA. Immunoprecipitation analysis of the translation product resulted in the identi®cation of a protein with an apparent size of 65 kDa on reducing SDS-polyacrylamide gels ( Figure 6A ). This protein was also recognized by an antiserum directed against the putative human ortholog MCRS1 (a-p78), whereas the translation product was not recognized by non-speci®c immunoglobulins present in the pre-immune serum ( Figure  6A ). To detect the cellular TOJ3 protein, immunoblot analysis was performed using cell extracts from normal QEF and from the v-jun-transformed cell lines Q/d3 or VJ. Both the a-TOJ3 and a-p78 antibodies speci®cally recognized a 65-kDa protein in the v-jun-transformed cell line VJ and in conditionally transformed Q/d3 cells cultured under permissive conditions but low levels of this protein were also detectable in normal QEF or in reverted Q/d3 cells upon depletion of doxycycline ( Figure 6B ). Because in these cells no TOJ3 mRNA was detected by Northern hybridization (cf. Figures 1  and 5 ), this result suggests that the TOJ3 protein may be of high stability accumulating to a basal level from low amounts of mRNA. However, the amount of TOJ3 protein is signi®cantly higher in cells transformed by v-jun compared to untransformed cells and thus correlates qualitatively with its mRNA levels in these cell types. To test, whether TOJ3 protein is also expressed at increased levels in v-jun-transformed chicken embryo ®broblasts (CEF), representing the cell system in which the v-jun oncogene was originally isolated (Maki et al., 1987) , extracts from normal CEF, and from primary CEF transfected with the retroviral vector RCAS-VJ0 carrying the gag-jun oncogene were tested ( Figure 6C ). As in v-juntransformed quail cells ( Figure 6B ), a 65-kDa TOJ3-speci®c protein is expressed at higher levels in gag-juntransformed CEF compared to normal CEF ( Figure 6C ).
Overexpressed TOJ3 induces cell transformation
The speci®c activation of TOJ3 in v-jun-transformed cells prompted us to test if overexpression of TOJ3 by itself would induce detectable changes in ®broblast morphology. Hence, the quail TOJ3 coding sequence was inserted into the replication-competent retroviral RCAS vector (Hughes et al., 1987) , and the construct RCAS-TOJ3 was transfected into QEF and into CEF. Parallel transfections of the RCAS-VJ0 construct carrying gag-jun resulted in full transformation manifested by focus formation after 1 week, whereas no prominent foci were induced by RCAS-TOJ3 (data not shown). However, when suspended into semi-solid medium, cells overexpressing the TOJ3 gene were capable of anchorage-independent growth (Figure 7) . Although TOJ3 induced colonies were smaller in size than colonies derived from cells transformed by the jun oncogene, this result clearly indicates that cells transfected by RCAS-TOJ3 display some of the typical parameters of the transformed state. ]methionine-labeled in vitro transcription/ translation reactions using each 1 mg of the plasmid construct pBS-TOJ3 encoding the 530 amino acid quail TOJ3 protein as template and 15 ml of immunoanity puri®ed polyclonal TOJ3 antibodies (a-TOJ3) or 1 ml of antiserum (a-p78) speci®c for the human p78 (MCRS1) protein or 1 ml of normal rabbit serum (NRS). Immunoprecipitated proteins were resolved by SDSpolyacrylamide(10%, w/v) gel electrophoresis. The¯uorograph was exposed for 6 days using an intensifying screen. ) cultured in the presence (time 0) or after 6 days in the absence of doxycycline (6 days) were separated by SDSpolyacrylamide(10%, w/v) gel electrophoresis and analysed by immunoblotting using TOJ3 or p78-speci®c antibodies and an enhanced chemoluminescence (ECL) detection system. As a titer control for the a-TOJ3 polyclonal antibodies, 10 ng of recombinant p9
TOJ3 protein used as immunogen were analysed in parallel. (C) Extracts derived from equal cell numbers (1.25610 5 ) of normal CEF and of CEF freshly transformed by RCAS-VJ0 carrying the gag-jun oncogene were analysed as above using a-TOJ3 antibodies. The positions and sizes of quail or chicken TOJ3 proteins and positions of protein size markers are indicated in the margins
Discussion
To functionally dissect transformation pathways emerging downstream of oncogenic transcription factors like Jun, the identi®cation of target genes dierentially expressed in cells transformed by these oncoproteins has become an indispensable prerequisite. Application of various techniques involving subtractive cloning or oligonucleotide microarrays has revealed the existence of numerous genes deregulated in cells transformed by oncogenic transcription factors like Jun, Fos or Myc, indicating that cell transformation apparently involves changes in the expression patterns of multiple genes (Boyd and Farnham, 1999; Dang, 1999; Coller et al., 2000; Ozanne et al., 2000; Rinehart-Kim et al., 2000) .
We have identi®ed four novel target genes of the oncogenic transcription factor Jun, represented by the RDA clones TOJ2, TOJ3, TOJ5, and TOJ6 (see Table  1 ) which could be assigned to known genes except of TOJ5 (see above). These genes are speci®cally activated in cells transformed by the v-jun oncogene in comparison to cells transformed by other oncogenic agents or to normal cells. The immediate induction of TOJ3 (cf. Figure 4) suggests that transcriptional activation of this target is directly mediated by the oncogenic transcription factor v-Jun. TOJ2 presumably represents the quail gene encoding the a7 subunit of nicotinic acetylcholine receptor (Schoepfer et al., 1990; Cordero-Erausquin et al., 2000) . TOJ6 is derived from the gene encoding the myosin binding protein-H (MyBP-H) which belongs to a set of myosin-associated proteins in vertebrate muscle cells (Vaughan et al., 1993) . The possible function of these proteins in the regulation of muscle contraction is still unknown, and so is the function of MyBP-H in v-jun-induced cell transformation. Distinct muscle cell speci®c genes including myosin are downregulated in v-jun-transformed myoblasts (Su et al., 1991; Grossi et al., 1991) , possibly due to a functional antagonism between myogenic transcription factors and Jun (Bengal et al., 1992) .
The 530-amino acid TOJ3 protein migrates with an apparent size of 65 kDa which is higher than its predicted M r of 57 929. Aberrant migration has been also observed for the 462-amino acid MSP58 protein migrating with an apparent size of 58 kDa (Ren et al., 1998) , and for the 534-amino acid MCRS1 (p78) protein with migration sizes of 78, 62 and 55 kDa (Bruni and Roizman, 1998) . Apart from the 84 amino terminal residues, TOJ3 is highly related to the mammalian MCRS1 proteins and thus may represent the MCRS1 quail ortholog (cf. Figure 3) . The cell cycle-regulated factor p78 possibly controls the herpes simplex virus 1 (HSV-1) protein ICP22 via proteinprotein interaction (Bruni and Roizman, 1998) . The MSP58 protein was identi®ed as the interacting partner of p120, a proliferation-related nucleolar protein present at signi®cantly elevated levels in most human tumor cells (Ren et al., 1998; Freeman et al., 1988) . Both p78 and MSP58 are localized as dense bodies or microspherules within the nucleoli, respectively (Bruni and Roizman, 1998; Ren et al., 1998) and may be involved in the formation of ribosomal particles (Hozak, 1995) . Intriguingly, hyperactivity of nucleolar function and dierences between nucleolar proteins compared to non-tumor tissues are major characteristics of cancer cells (Ren et al., 1998) .
The TOJ3 protein is featured by a bipartite nuclear localization signal motif and by a forkhead associated domain (FHA) present in the carboxyl terminus. FHA domains encompass three highly conserved blocks containing several predicted b-sheets and are conserved between eukaryotic and prokaryotic proteins (Hofmann and Bucher, 1995; Durocher et al., 1999; Li et al., 2000) . In eukaryotes, FHA domains are found almost exclusively in nuclear proteins which are linked to the control of transcription, DNA repair, or cell cycle progression (Hofmann and Bucher, 1995; Durocher et al., 1999; Li et al., 2000) and most of these FHA-proteins also contain a bipartite nuclear localization sequence motif (Hofmann and Bucher, 1995) . The presence of these sequence motifs and the close relationship to MCRS1 proteins (cf. Figure 3) suggests that TOJ3 is translocated into the nucleus like its human counterparts. FHA domains presumably mediate protein-protein interactions, and it has recently been shown that distinct FHA domains are competent to bind to phosphopeptides or to peptides in a phosphorylation-dependent manner (Durocher et al., 1999; Wang et al., 2000) . Indeed, the FHA domain of MSP58 is required for protein-protein interaction with p120 as demonstrated by analysis of MSP58 deletion mutants (Ren et al., 1998) .
Apparently, multiple genes are dierentially expressed in cells transformed by v-Jun or by other oncogenic transcription factors Dang, 1999; Ozanne et al., 2000; Rinehart-Kim et al., 2000; Cohen et al., 2001) , and the major challenge will be to identify those target genes whose dierential expression ultimately leads to initiation and maintenance of cell transformation Ozanne et al., 2000) . Hence, the identi®cation of transformation-relevant target genes acting as eectors downstream of oncogenic transcription factors represents an important step in deciphering this complex network. In this context, it is remarkable that cells transfected with a retroviral construct encoding TOJ3 grow in semi-solid medium and thus display a characteristic feature of neoplastic transformation. Based on this capacity to induce partial cell transformation, the TOJ3 gene described here presumably belongs to the class of genes that are directly involved in jun-induced cell transformation like the recently identi®ed jun target gene HB-EGF . Due to its transient activation, it is conceivable that TOJ3 is required in the initiating phase of v-juninduced cell transformation possibly triggering another yet to be identi®ed factor necessary for maintenance of the transformed phenotype. However, a direct interaction of v-Jun with the TOJ3 promoter remains to be proven. Likewise, examination of a possible AP-1 involvement in the regulation of mammalian TOJ3 homologs is a necessary task to perform. Finally, further characterization of the genes identi®ed here has to be pursued in order to determine the functional role of their protein products in the jun-induced transformation process.
Material and methods
Cells and retroviruses
Fertile Japanese quail (Coturnix japonica) or SPAFAS chicken (Gallus gallus) eggs were obtained from Hagn Ge¯uÈ gel (Andorf, Austria) or from Lohmann Tierzucht (Cuxhaven, Germany), respectively. Preparation and cultivation of quail or chicken embryo ®broblasts (QEF), calcium phosphate mediated DNA transfection, conditional cell transformation and detection of transformation events was performed as described (Bister et al., 1977; Hartl and Bister, 1998; Bader et al., 2000) . Cells were cultured in growth medium as described (Bister et al., 1977; Oberst et al., 1999) . Infection of QEF with avian retroviruses was performed as described previously (Hartl and Bister, 1998 ) using avian sarcoma virus 17 (ASV17) carrying the v-jun oncogene (Maki et al., 1987) , or avian retrovirus NK24 carrying the v-fos oncogene (Nishizawa et al., 1987) . Q/d3 and Q/VII are cell lines conditionally transformed by a v-jun allele controlled by a doxycycline-dependent reverse-transactivator rtTA (Bader et al., 2000) and Q/tM on is an analog line transformed by the v-myc oncogene (Oberst et al., 1999) . Cells were cultured in medium with or without doxycycline as described previously (Oberst et al., 1999; Bader et al., 2000) . The following established lines of non conditional transformed QEF were used in this study: VJ, developed from continuously passaged QEF transfected with the retroviral construct RCAS-VJ1 (see below) carrying a v-jun allele; MH2A10, transformed by the v-myc and v-mil oncogenes of avian acute leukemia virus MH2 (Jansen et al., 1983) ; Q8, transformed by the v-myc oncogene of avian acute leukemia virus MC29 (Bister et al., 1977) ; QT6, derived from a methylcholanthrene-induced ®brosarcoma (Moscovici et al., 1977) ; R(-)3, transformed by the v-src oncogene of RSV (Bister et al., 1977) . The retroviral constructs RCAS-VJ1 and RCAS-MC29 used for the generation of transformed QEF mass cultures have been described previously Tikhonenko and Linial, 1992; Bister, 1995, 1998) . For serum stimulation, QEF were cultivated for 2 days in chicken serum-free growth medium containing 0.5% newborn calf serum. Then, the medium was replaced by chicken serum-free medium containing 0.25% newborn calf serum. After 2 days, cells were stimulated with serum growth factors by replacement with medium containing 13% newborn calf serum and 2% chicken serum.
Representational difference analysis
Representational dierence analysis (RDA) was performed as described by Hubank and Schatz (1994) using the standard 24mer and 12mer primers R-Bgl24, R-Bgl12, J-Bgl24, JBgl12, N-Bgl24, and N-Bgl12 synthesized on an Applied Biosystems 391 DNA synthesizer. As source for the generation of driver cDNA, RNA was isolated from Q/d3 cells (Bader et al., 2000) which have been depleted of doxycycline for 8 days. Then, doxycycline was added to an aliquot of the doxycycline-depleted cell population and RNA was isolated 24 h later serving as source for tester cDNA generation. For ®rst-strand cDNA synthesis, a 50 ml reaction mixture containing 2 mg of 26poly(A) + selected RNA, 50 mM Tris-HCl (pH 8.3), 75 mM potassium chloride, 3 mM magnesium chloride, 1 mM dithiothreitol (DTT), 4 mg of bovine serum albumine, 2 mM each of dGTP, dATP, dTTP and dCTP, and 2.5 mg of oligo(dT) primer, and 600 U M-MLV reverse transcriptase was incubated at 378C for 1 h. Second-strand synthesis was performed at 378C for 3 h in a 100-ml reaction volume by adding 10 ml of 106ligation buer [188 mM Tris-HCl pH 8.3, 906 mM KCl, 46 mM MgCl 2 , 37.5 mM DTT, 1.5 mM b-nicotinamide-adenine dinucleotide, 100 mM (NH 4 ) 2 SO 4 ], 25 U DNA polymerase from Escherichia coli (E.coli), 2.25 U RNAseH, and 5 U E.coli DNA ligase. The reaction mixture was extracted with phenol and cDNA was ethanol precipitated. Generation of cDNA representations, hybridizations and selective ampli®cations were carried out as described (Hubank and Schatz, 1994) except that 2 mg of DpnII-cut cDNA were initially ligated with R-Bgl12/24 adaptors and that ampli®cation reactions were carried out in 100-ml volumes containing each 2 ml of the diluted ligation mixture, 10 mM Tris-HCl pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 0.01% (w/v) gelatine, 2 mg of BSA, 0.25 mM of each dATP, dCTP, dGTP, dTTP, and 2 mg of RBgl24 primer. DNA from the third dierence product was digested with DpnII and ligated into a BamHI-cut pUC19 vector.
DNA cloning and nucleic acid analysis
Five mg of 26poly(A) + selected RNA from Q/d3 cells which served as source for tester cDNA generation (see above) were used to construct a cDNA library using the lgt10 vector (Stratagene) as described . DNA labeling, plaque hybridization, DNA sequencing and interpretation were performed as described Bister, 1995, 1998) using the program OMIGA (Accelrys) and the BLAST algorithm (Altschul et al., 1997) . Subcloned cDNA inserts were sequenced as described using pUC primers and internal gene-speci®c primers. Primer extension analysis was done as described previously (Hartl and Bister, 1998) using 5 mg poly(A) + RNA from Q/d3 cells and an oligodeoxynucleotide (5'-CGCGGCGCCATCTTGG-TTAAGGGCAAAGAT-3') complementary to TOJ3 cDNA. Sequence determination of the extended product was performed after rapid ampli®cation of cDNA ends (RACE) (Edwards et al., 1991 ) using a 5'-RACE-system (Gibco-BRL) and the oligodeoxynucleotides 5'-CCACAGGCCCCGCC-GAGGCCTCACCA-TCAC-3' and 5'-CTACTTCCGGAA-GCGGATATGACGTCATTG-3' as gene speci®c primers (GSP) 1 and 2, respectively. De®nition of the TOJ3 mRNA 3'-end was carried out using an analog 3'-RACE system (Gibco-BRL) and oligodeoxynucleotides 5'-ATCAAGACG-GAGGCAGCCAAGATGGCCCAG-3' and 5'-CTGCTCTG-ATACATCCCCTCCAGCCCTACA-3' as GSP 1 and 2, respectively.
RNA isolation and Northern analysis were performed as described Bister, 1995, 1998) . Hybridization probes for Northern analyses included RDA cDNA fragments corresponding to the quail TOJ3 gene (175 bp) and to the quail clones TOJ2 (258 bp), TOJ5 (234 bp), TOJ6 (161 bp). Further probes were generated using the EcoRI insert fragment of the 620-bp quail BKJ cDNA clone pVQ80 , a 740-bp Bsu36I/HincII fragment containing the c-jun chicken coding region (nt 456 ± 1196; Nishimura and Vogt, 1988) , the EcoRI insert fragment of the 1213-bp quail GAPDH cDNA clone 67 (Weiskirchen et al., 1993) , the 1285-bp EcoRI/XbaI insert fragment of clone RcFos (Hartl and Bister, 1998) encompassing the coding region of chicken c-fos cDNA (MoÈ lders et al., 1987) , and the 1175-bp PstI/SspI v-myc-speci®c fragment of pMC29-B (Bister et al., 1987) as templates.
Polyclonal antiserum generation and immunoaffinity chromatography TOJ3 speci®c antiserum was generated using a puri®ed 77-amino acid polypeptide encompassing an amino terminal segment of the quail TOJ3 protein as immunogen. For construction of a relevant bacterial expression plasmid, a 203-bp BamHI fragment of clone TOJ3_F4 (cf. Figure 2) was treated with mung bean nuclease to remove 5'-overhangs and then ligated into a EcoRI-cut pGEX-2T vector (Amersham Pharmacia Biotech) which has been treated with T4 DNA polymerase to ®ll in 5'-overhangs. The resulting expression plasmid pGEX-2T-p9 TOJ3 encoding a 301-amino acid glutathione S-transferase fusion protein (GST-p9 TOJ3 ) from which amino acids 228 ± 295 are derived from the TOJ3 amino terminus (TOJ3 amino acids 8 ± 75) was veri®ed by DNA sequencing using pGEX-speci®c primers. The plasmid construct was transformed into Escherichia coli strain BL21-CodonPlus(DE3)-RIL (Stratagene). An overnight culture was diluted 1 : 100 in NZCYM medium containing 100 mg ampicillin and 25 mg chloramphenicol per liter. Bacteria were grown at 378C to an optical density of 0.5 at 600 nm, protein synthesis was induced by the addition of isopropyl-b-D-thiogalactoside (IPTG) to a ®nal concentration of 0.4 mM, and incubation was continued for 2 h. All subsequent steps were carried out at 48C unless otherwise noted. Cells were collected by centrifugation and resuspended in 20 ml buer A (50 mM NaH 2 PO 4 /NaHPO 4 pH 7.2, 100 mM NaCl, 0.5 mM DTT) per liter of the original bacterial culture. Bacteria were lysed by soni®cation. The clari®ed supernatant was fractionated by ammonium sulfate precipitation. The precipitate formed between 30 and 40% saturation was dissolved in buer A and loaded onto a Superdex-75 (16/60) gel ®ltration column equilibrated in buer A using a fast performance liquid chromatography (FPLC) system (Amersham Pharmacia Biotech). GST-p9
TOJ3 containing fractions were concentrated using Centriprep-10 ultra®ltration ®lter (Amicon).
For cleavage of the TOJ3 polypeptide from the GST portion, the fusion protein puri®ed from one liter of bacterial culture was cleaved with 20 U thrombin protease at 258C for 16 h followed by gel ®ltration chromatography performed under the same conditions as outlined above. Pooled protein fractions containing the puri®ed 77-amino acid carboxylterminus of the GST-fusion protein consisting of amino acids 8 ± 75 from TOJ3¯anked by 3 amino terminal and 6 carboxyl terminal amino acids derived from the pGEX-2T vector were analysed by photometry and SDS-gelelectrophoresis, and the identity of this polypeptide (M r =7581) was con®rmed by liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS) (kindly performed by F Lottspeich, Max-Planck-Institute of Biochemistry, Martinsried, Germany). The ®nal yield of puri®ed p9
TOJ3 was approximately 3 mg per liter of bacterial liquid culture. For antigen preparation, 150 mg of p9 TOJ3 dissolved in 500 ml buer A were mixed with 500 ml complete Freund's adjuvant and injected intradermally into an 8-week-old female rabbit (Chinchilla bastard). The immunization procedure was repeated three times in 4-week intervals using incomplete Freund's adjuvant. Serum from blood was obtained after overnight storage at 48C and subsequent centrifugation at 1200 g for 10 min. Puri®cation of polyclonal TOJ3-speci®c antibodies was performed by immunoanity chromatography. All steps were carried out at 48C. For coupling of antigen to a solid matrix, 15 mg of puri®ed p9 TOJ3 polypeptide dissolved in 1 ml of buer A were mixed with 500 ml washed and equilibrated A-Gel 15 beads (Bio-Rad) and incubated for 16 h. Then, the beads were transferred into a 5-ml Econo column (Bio-Rad) and washed subsequently with 5 ml of buer A, with 5 ml of a solution containing 1 M NaCl and 10 mM Tris-HCl pH 7.5, with 5 ml of 100 mM glycine pH 2.5, and with 5 ml of buer A. 500 ml of TOJ3-speci®c antiserum which has been clari®ed by heating to 568C for 30 min and subsequent centrifugation (12 000 g for 10 min) were passed through the column ®ve times. The loaded column was then washed with 5 ml of a solution containing 1 M NaCl and 10 mM Tris-HCl pH 7.5. Bound antibodies were eluted with 5 ml of 100 mM glycine pH 2.5. Immediately after elution, the eluate was neutralized by adding 500 ml 1 M Tris HCl pH 8.0. The additional polyclonal antiserum used in this study was directed against the human p78 (MCRS1) protein (kindly provided by B Roizman, The University of Chicago, Chicago, USA).
Protein analysis
In vitro transcriptions and translations and immunoprecipitation analysis of in vitro translated proteins was done as described (Hartl and Bister, 1998) . To construct the DNA template pBS-TOJ3, the EcoRI insert fragment of clone TOJ3_F1 encoding the 530-amino acid TOJ3 protein was ligated into pBluescript SK II(+) (Stratagene). For immunoblot analysis, proteins separated by SDS polyacrylamide gelelectrophoresis were transferred as described onto ECL Hybond membranes and detected using an enhanced chemoluminescence (ECL)-Western blotting detection system (Amersham Pharmacia Biotech). After blocking in a solution containing 10 mM sodium phosphate pH 7.2, 150 mM sodium chloride, 0.1% (v/v) Tween 20, 5% (w/v) non fat dry milk, ®lters were incubated for 1 h at room temperature in 10 mM sodium phosphate pH 7.2, 150 mM sodium chloride, 0.1% (v/v) Tween 20 (PBS-T) containing 1/ 400 (v/v) or 1/1000 (v/v) of a-TOJ3 or a-p78, respectively. After washing in PBS-T, ®lters were incubated for 45 min in PBS-T containing 1/1333 (v/v) horseradish peroxidase linked to anti-rabbit IgG (Amersham Pharmacia Biotech). After repeating the washing step, ®lters were incubated for 60 s in a detection solution containing the cyclic diacylhydrazide luminol (Amersham Pharmacia Biotech) leading to oxidation and excitation of luminol by antibody-linked peroxidase. Subsequent light emission was monitored by immediate exposure of the ®lter to an X-ray ®lm (Eastman Kodak Company) for 9 min (a-TOJ3) or for 4 min (a-p78).
